INS NYC 2024 Program

Speaker Portal Presentations	Program Schedule 02/14/2024 01:00 pm - 04:00 pm Room: West Side Ballroom - Salon 1 CE Workshop 4 (Movement Disorders SIG) Session Host Name: Sam J Crowley Host's Role: Introduction Deep brain stimulation: Neuropsychological management and global perspectives Sponsored by INS Movement Disorders Special Interest Group Summary Abstract: Deep brain stimulation (DBS) is a critical neurosurgical intervention for disease management in more than ten million people diagnosed with Parkinson’s disease worldwide. This notably does not account for the rapidly growing numbers of patients diagnosed with other movement disorders, epilepsy, Tourette’s disorder, obsessive compulsive disorder, depression, and dementia, for which DBS has nascent and rapidly evolving and valuable indications. Due to the growth of clinical DBS applications along with increased life expectancy, younger ages for DBS utility, and heightened demand for minimally invasive techniques to optimize outcome across neurological, psychiatric, and medical populations, the need for greater engagement in neuropsychological management of DBS populations is growing exponentially. In fact, DBS demand is growing faster than neuropsychological training programs are growing both in numbers of trainees and in teaching about the use of neuropsychology for surgical decision-making. This means there is a great need to train neuropsychologists to meet the needs of this growing DBS population (along with new targets and a better understanding of after care etc. the need will only grow). This CE workshop will review neuromodulatory options for neurological, neuropsychiatric, and medical diseases and disorders along with the integral role of the neuropsychologist in the surgical workup, disease management, and for prognosis. We will review diseases and disorders for which neuro-modulation is indicated, as well as the critical role of the neuropsychologist among the interdisciplinary team. We will discuss the nuts and bolts of neuropsychological assessment- including standards of care and predictors of cognitive and psychological risk- in these populations. We will conclude by addressing important cross-cultural considerations when working with diverse neurosurgical populations globally. Number of Credit Hours: 3.0 Level of Instruction: Intermediate Learning Objectives: 1. Describe the neurological, neuropsychiatric, and medical indications for DBS intervention 2. Discuss standards of care, healthcare disparities, and predictors of cognitive and psychological risk in neurosurgical populations across diverse patient populations and cultures 3. Apply these standards to an interdisciplinary care team model for DBS neurosurgical planning to optimize patient prognosis Presenter(s): Christina A Palmese, PhD The Icahn School of Medicine at Mount Sinai Hospital Christina A Palmese PhD, ABPP-CN is an Associate Professor in Neurology and Psychiatry and Director of Clinical Neuropsychological Services in Neurology at The Mount Sinai Hospital, where she also is Director of Continuing Education for Psychology within the Icahn School of Medicine. She earned her PhD from the CUNY Graduate Center and completed her Fellowship at Columbia University Medical Center. She has authored numerous articles and book chapters on movement disorders, deep brain stimulation, and epilepsy, is on the editorial board and ad-hoc reviewer for several scientific journals, and holds leadership roles within national and international neuropsychology and movement disorder organizations. Kathryn Wyman-Chick, PsyD HealthPartners/Park Nicollet Struthers Parkinson's Center Kathryn A. Wyman-Chick, PsyD, ABPP-CN is a clinical neuropsychologist at Struthers Parkinson’s Center, a Parkinson’s Foundation Center of Excellence, who routinely works with DBS populations and patients with Lewy body disease. She is an NIH-funded principal investigator focused on diagnosis and treatment of Lewy body disease, including Parkinson’s disease and dementia with Lewy bodies. In 2022, she received a research award from the International Lewy Body Dementia Association. Dr. Wyman was also selected for highly competitive leadership programs through the Movement Disorder Society and the National Academy of Neuropsychology. She maintains active involvement in the Parkinson Study Group, as well as the Movement Disorder Special Interest Group of the International Neuropsychological Society. Michele York, PhD Baylor College of Medicine Michele K. York, PhD, ABPP-CN is a tenured Professor of Neurology and Psychiatry, Section Head of Neuropsychology in the Department of Neurology at Baylor College of Medicine (BCM) and the Neuropsychologist for the Parkinson’s Disease Research, Education and Clinical Center at the Michael E. DeBakey VA. She earned her MA and PhD in Clinical Psychology from Vanderbilt University and completed her internship and post-doctoral fellowship in Neuropsychology at BCM. She has won numerous university and national clinical and teaching awards and has published over 90 articles and book chapters on neuropsychological aspects of neurodegenerative disorders, particularly movements disorders and deep brain stimulation.

Speaker Portal Presentations

02/14/2024
01:00 pm - 04:00 pm
Room: West Side Ballroom - Salon 1

CE Workshop 4 (Movement Disorders SIG)

Session Host Name: Sam J Crowley
Host's Role: Introduction

Deep brain stimulation: Neuropsychological management and global perspectives

Summary Abstract:

Deep brain stimulation (DBS) is a critical neurosurgical intervention for disease management in more than ten million people diagnosed with Parkinson’s disease worldwide. This notably does not account for the rapidly growing numbers of patients diagnosed with other movement disorders, epilepsy, Tourette’s disorder, obsessive compulsive disorder, depression, and dementia, for which DBS has nascent and rapidly evolving and valuable indications.

Due to the growth of clinical DBS applications along with increased life expectancy, younger ages for DBS utility, and heightened demand for minimally invasive techniques to optimize outcome across neurological, psychiatric, and medical populations, the need for greater engagement in neuropsychological management of DBS populations is growing exponentially. In fact, DBS demand is growing faster than neuropsychological training programs are growing both in numbers of trainees and in teaching about the use of neuropsychology for surgical decision-making. This means there is a great need to train neuropsychologists to meet the needs of this growing DBS population (along with new targets and a better understanding of after care etc. the need will only grow).

This CE workshop will review neuromodulatory options for neurological, neuropsychiatric, and medical diseases and disorders along with the integral role of the neuropsychologist in the surgical workup, disease management, and for prognosis. We will review diseases and disorders for which neuro-modulation is indicated, as well as the critical role of the neuropsychologist among the interdisciplinary team. We will discuss the nuts and bolts of neuropsychological assessment- including standards of care and predictors of cognitive and psychological risk- in these populations. We will conclude by addressing important cross-cultural considerations when working with diverse neurosurgical populations globally.

Number of Credit Hours: 3.0

Level of Instruction: Intermediate

Learning Objectives:
1. Describe the neurological, neuropsychiatric, and medical indications for DBS intervention
2. Discuss standards of care, healthcare disparities, and predictors of cognitive and psychological risk in neurosurgical populations across diverse patient populations and cultures
3. Apply these standards to an interdisciplinary care team model for DBS neurosurgical planning to optimize patient prognosis

Presenter(s):

Christina A Palmese, PhD

The Icahn School of Medicine at Mount Sinai Hospital

Christina A Palmese PhD, ABPP-CN is an Associate Professor in Neurology and Psychiatry and Director of Clinical Neuropsychological Services in Neurology at The Mount Sinai Hospital, where she also is Director of Continuing Education for Psychology within the Icahn School of Medicine. She earned her PhD from the CUNY Graduate Center and completed her Fellowship at Columbia University Medical Center. She has authored numerous articles and book chapters on movement disorders, deep brain stimulation, and epilepsy, is on the editorial board and ad-hoc reviewer for several scientific journals, and holds leadership roles within national and international neuropsychology and movement disorder organizations.

Kathryn Wyman-Chick, PsyD

HealthPartners/Park Nicollet Struthers Parkinson's Center

Kathryn A. Wyman-Chick, PsyD, ABPP-CN is a clinical neuropsychologist at Struthers Parkinson’s Center, a Parkinson’s Foundation Center of Excellence, who routinely works with DBS populations and patients with Lewy body disease. She is an NIH-funded principal investigator focused on diagnosis and treatment of Lewy body disease, including Parkinson’s disease and dementia with Lewy bodies. In 2022, she received a research award from the International Lewy Body Dementia Association. Dr. Wyman was also selected for highly competitive leadership programs through the Movement Disorder Society and the National Academy of Neuropsychology. She maintains active involvement in the Parkinson Study Group, as well as the Movement Disorder Special Interest Group of the International Neuropsychological Society.

Michele York, PhD

Baylor College of Medicine

Michele K. York, PhD, ABPP-CN is a tenured Professor of Neurology and Psychiatry, Section Head of Neuropsychology in the Department of Neurology at Baylor College of Medicine (BCM) and the Neuropsychologist for the Parkinson’s Disease Research, Education and Clinical Center at the Michael E. DeBakey VA. She earned her MA and PhD in Clinical Psychology from Vanderbilt University and completed her internship and post-doctoral fellowship in Neuropsychology at BCM. She has won numerous university and national clinical and teaching awards and has published over 90 articles and book chapters on neuropsychological aspects of neurodegenerative disorders, particularly movements disorders and deep brain stimulation.